SS Innovations CEO Takes 100,000 Shares To Settle $300,000 In Unpaid Pay
The surgical-robotics company is building its U.S. operations and pursuing regulatory clearance for overseas expansion.
SS Innovations International, which makes surgical robotic systems, settled $300,000 in unpaid pay owed to Chairman and CEO Dr. Sudhir Srivastava with 100,000 shares Tuesday. The exchange valued each share at $3.00, according to the company's SEC filing, above SSII's $1.33 price at Tuesday's close.
Pay Owed Becomes Equity
Srivastava made the purchase through Sushruta, his holding company. He paid for the shares by surrendering compensation the company already owed him.
The exchange settles that pay obligation with stock, preserving the cash that a cash payment would have required. It also puts 100,000 additional shares in the hands of the chief executive's holding company.
Building Beyond Its Indian Base
SS Innovations is preparing to take its SSi Mantra system further beyond India, where the company said it had established a leading position. Its push includes building U.S. operations and a management team based there.
The company promoted Dr. Vishwa Srivastava to president Friday from chief executive officer for Asia Pacific, according to its management announcement. It appointed Gary Lo chief financial officer, with both executives based in the United States.
Vishwa Srivastava said the company plans to develop the infrastructure and operations needed to expand the system's reach in the United States and globally. Regulatory work is part of that effort: SS Innovations said it had been responding to FDA questions on its application to market the system and was seeking European Union CE certification.
Systems Bring Recurring Sales
SSi Mantra supports procedures in urology, general surgery, gynecology, colorectal surgery, thoracic surgery and cardiac surgery. SS Innovations sells to hospitals directly and through distributors, offering outright purchases, installment payments and pay-per-procedure arrangements.
The business extends beyond the robotic systems themselves. Instruments, accessories and services used with the equipment generate recurring sales.
As of December 31, 2025, the company had installed 168 systems across 10 countries, including 154 in India. More than 7,800 procedures had been performed using its systems across 153 hospitals by that date.
SS Innovations said its Indian research and development facility is completing healthcare technologies that it plans to introduce in the coming months.
Sources
- 8-K Filing — SS Innovations International, Inc. (SSII) — SEC EDGAR
- SS Innovations Strengthens Management Team in Preparation — globenewswire.com